Literature DB >> 18820998

Transport mechanisms of carnosine in SKPT cells: contribution of apical and basolateral membrane transporters.

Dilara Jappar1, Yongjun Hu, Richard F Keep, David E Smith.   

Abstract

PURPOSE: The aim of this study was to investigate the transport properties of carnosine in kidney using SKPT cell cultures as a model of proximal tubular transport, and to isolate the functional activities of renal apical and basolateral transporters in this process.
METHODS: The membrane transport kinetics of 10 microM [3H]carnosine was studied in SKPT cells as a function of time, pH, potential inhibitors and substrate concentration. A cellular compartment model was constructed in which the influx, efflux and transepithelial clearances of carnosine were determined. Peptide transporter expression was probed by RT-PCR.
RESULTS: Carnosine uptake was 15-fold greater from the apical than basolateral surface of SKPT cells. However, the apical-to-basolateral transepithelial transport of carnosine was severely rate-limited by its cellular efflux across the basolateral membrane. The high-affinity, proton-dependence, concentration-dependence and inhibitor specificity of carnosine supports the contention that PEPT2 is responsible for its apical uptake. In contrast, the basolateral transporter is saturable, inhibited by PEPT2 substrates but non-concentrative, thereby, suggesting a facilitative carrier.
CONCLUSIONS: Carnosine is expected to have a substantial cellular accumulation in kidney but minimal tubular reabsorption in blood because of its high influx clearance across apical membranes by PEPT2 and very low efflux clearance across basolateral membranes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18820998      PMCID: PMC2913304          DOI: 10.1007/s11095-008-9726-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  49 in total

1.  PEPT2-mediated uptake of neuropeptides in rat choroid plexus.

Authors:  N S Teuscher; R F Keep; D E Smith
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

2.  Distinct transport characteristics of basolateral peptide transporters between MDCK and Caco-2 cells.

Authors:  K Sawada; T Terada; H Saito; K Inui
Journal:  Pflugers Arch       Date:  2001-10       Impact factor: 3.657

3.  Mechanism of intestinal absorption and renal reabsorption of an orally active ace inhibitor: uptake and transport of fosinopril in cell cultures.

Authors:  C Shu; H Shen; U Hopfer; D E Smith
Journal:  Drug Metab Dispos       Date:  2001-10       Impact factor: 3.922

4.  Cloning of a lymphatic peptide/histidine transporter.

Authors:  K Sakata; T Yamashita; M Maeda; Y Moriyama; S Shimada; M Tohyama
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

5.  Cloning and characterization of the gene encoding the mouse peptide transporter PEPT2.

Authors:  I Rubio-Aliaga; M Boll; H Daniel
Journal:  Biochem Biophys Res Commun       Date:  2000-09-24       Impact factor: 3.575

6.  Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2.

Authors:  M Sugawara; W Huang; Y J Fei; F H Leibach; V Ganapathy; M E Ganapathy
Journal:  J Pharm Sci       Date:  2000-06       Impact factor: 3.534

7.  Functional evidence for presence of PEPT2 in rat choroid plexus: studies with glycylsarcosine.

Authors:  N S Teuscher; A Novotny; R F Keep; D E Smith
Journal:  J Pharmacol Exp Ther       Date:  2000-08       Impact factor: 4.030

8.  Functional expression of novel peptide transporter in renal basolateral membranes.

Authors:  T Terada; K Sawada; T Ito; H Saito; Y Hashimoto; K Inui
Journal:  Am J Physiol Renal Physiol       Date:  2000-11

Review 9.  Physiological and pharmacological implications of peptide transporters, PEPT1 and PEPT2.

Authors:  K Inui; T Terada; S Masuda; H Saito
Journal:  Nephrol Dial Transplant       Date:  2000       Impact factor: 5.992

10.  Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1.

Authors:  D A Groneberg; F Döring; P R Eynott; A Fischer; H Daniel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-09       Impact factor: 4.052

View more
  8 in total

1.  Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS).

Authors:  Manthena V Varma; Stefanus J Steyn; Charlotte Allerton; Ayman F El-Kattan
Journal:  Pharm Res       Date:  2015-07-09       Impact factor: 4.200

2.  THE EVALUATION OF PEPTIDE/HISTIDINE TRANSPORTER 1 (PHT1) FUNCTION: UPTAKE KINETICS UTILIZING A COS-7 STABLY TRANSFECTED CELL LINE.

Authors:  David J Lindley; Stephen M Carl; Stephanie A Mowery; Gregory T Knipp
Journal:  Rev Mex Cienc Farm       Date:  2011-10

Review 3.  Muscle carnosine metabolism and beta-alanine supplementation in relation to exercise and training.

Authors:  Wim Derave; Inge Everaert; Sam Beeckman; Audrey Baguet
Journal:  Sports Med       Date:  2010-03-01       Impact factor: 11.136

4.  Influence of genetic knockout of Pept2 on the in vivo disposition of endogenous and exogenous carnosine in wild-type and Pept2 null mice.

Authors:  Mohamed A Kamal; Huidi Jiang; Yongjun Hu; Richard F Keep; David E Smith
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-02-18       Impact factor: 3.619

5.  Histidine Metabolism and Function.

Authors:  Margaret E Brosnan; John T Brosnan
Journal:  J Nutr       Date:  2020-10-01       Impact factor: 4.798

6.  Oral anserine supplementation does not attenuate type-2 diabetes or diabetic nephropathy in BTBR ob/ob mice.

Authors:  Inge Everaert; Thibaux Van der Stede; Jan Stautemas; Maxime Hanssens; Cleo van Aanhold; Hans Baelde; Lynn Vanhaecke; Wim Derave
Journal:  Amino Acids       Date:  2021-07-15       Impact factor: 3.520

Review 7.  Ergogenic effects of β-alanine and carnosine: proposed future research to quantify their efficacy.

Authors:  John Caruso; Jessica Charles; Kayla Unruh; Rachel Giebel; Lexis Learmonth; William Potter
Journal:  Nutrients       Date:  2012-06-26       Impact factor: 5.717

8.  Carnosine treatment for gulf war illness: a randomized controlled trial.

Authors:  James Nicholas Baraniuk; Suliman El-Amin; Rebecca Corey; Rakib Rayhan; Christian Timbol
Journal:  Glob J Health Sci       Date:  2013-02-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.